{"name":"Ukrainian Medical Stomatological Academy","slug":"ukrainian-medical-stomatological-academy","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Oral L-arginine aspartate administration","genericName":"Oral L-arginine aspartate administration","slug":"oral-l-arginine-aspartate-administration","indication":"Erectile dysfunction","status":"phase_3"}]},{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Oral L-ornithine aspartate administration","genericName":"Oral L-ornithine aspartate administration","slug":"oral-l-ornithine-aspartate-administration","indication":"Hepatic encephalopathy","status":"phase_3"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"cardiovascular","drugs":[{"name":"Ramipril 5 MG","genericName":"Ramipril 5 MG","slug":"ramipril-5-mg","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"Oral L-arginine aspartate administration","genericName":"Oral L-arginine aspartate administration","slug":"oral-l-arginine-aspartate-administration","phase":"phase_3","mechanism":"L-arginine aspartate is a nitric oxide precursor that enhances endothelial function and vascular reactivity through increased NO production.","indications":["Erectile dysfunction","Cardiovascular insufficiency","Endothelial dysfunction"],"catalyst":""},{"name":"Oral L-ornithine aspartate administration","genericName":"Oral L-ornithine aspartate administration","slug":"oral-l-ornithine-aspartate-administration","phase":"phase_3","mechanism":"Oral L-ornithine aspartate administration increases ornithine levels in the body.","indications":["Hepatic encephalopathy"],"catalyst":""},{"name":"Ramipril 5 MG","genericName":"Ramipril 5 MG","slug":"ramipril-5-mg","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":3,"phaseCounts":{"phase_3":2,"marketed":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}